Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Fatigue Measurements in Systemic Lupus Erythematosus.

Barbacki A, Petri M, Aviña-Zubieta A, Alarcón GS, Bernatsky S.

J Rheumatol. 2019 Feb 1. pii: jrheum.180831. doi: 10.3899/jrheum.180831. [Epub ahead of print]

PMID:
30709953
2.

Persistent Disease Activity Remains a Burden for Patients with Systemic Lupus Erythematosus.

Peschken CA, Wang Y, Abrahamowicz M, Pope J, Silverman E, Sayani A, Iczkovitz S, Ross J, Zummer M, Tucker L, Pineau C, Levy D, Hudson M, Hitchon CA, Huber AM, Smith CD, Avina-Zubieta A, Arbillaga H, Chédeville G, Wynant W, Fortin PR; CaNIOS 1000 Faces Investigators.

J Rheumatol. 2019 Feb;46(2):166-175. doi: 10.3899/jrheum.171454. Epub 2018 Sep 15.

PMID:
30219771
3.

Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus.

Keeling SO, Alabdurubalnabi Z, Avina-Zubieta A, Barr S, Bergeron L, Bernatsky S, Bourre-Tessier J, Clarke A, Baril-Dionne A, Dutz J, Ensworth S, Fifi-Mah A, Fortin PR, Gladman DD, Haaland D, Hanly JG, Hiraki LT, Hussein S, Legault K, Levy D, Lim L, Matsos M, McDonald EG, Medina-Rosas J, Pardo Pardi J, Peschken C, Pineau C, Pope J, Rader T, Reynolds J, Silverman E, Tselios K, Suitner M, Urowitz M, Touma Z, Vinet E, Santesso N.

J Rheumatol. 2018 Oct;45(10):1426-1439. doi: 10.3899/jrheum.171459. Epub 2018 Sep 1.

4.

RNA-Seq Analysis of Gene Expression, Viral Pathogen, and B-Cell/T-Cell Receptor Signatures in Complex Chronic Disease.

Bouquet J, Gardy JL, Brown S, Pfeil J, Miller RR, Morshed M, Avina-Zubieta A, Shojania K, McCabe M, Parker S, Uyaguari M, Federman S, Tang P, Steiner T, Otterstater M, Holt R, Moore R, Chiu CY, Patrick DM; Complex Chronic Disease Study Group.

Clin Infect Dis. 2017 Feb 15;64(4):476-481. doi: 10.1093/cid/ciw767.

5.

Medication Nonadherence in Systemic Lupus Erythematosus: A Systematic Review.

Mehat P, Atiquzzaman M, Esdaile JM, AviÑa-Zubieta A, De Vera MA.

Arthritis Care Res (Hoboken). 2017 Nov;69(11):1706-1713. doi: 10.1002/acr.23191. Epub 2017 Sep 21. Review.

6.

Development of the Lupus Interactive Navigator as an Empowering Web-Based eHealth Tool to Facilitate Lupus Management: Users Perspectives on Usability and Acceptability.

Neville C, Da Costa D, Rochon M, Peschken CA, Pineau CA, Bernatsky S, Keeling S, Avina-Zubieta A, Lye E, Eng D, Fortin PR.

JMIR Res Protoc. 2016 May 30;5(2):e44. doi: 10.2196/resprot.4219.

7.

Disease-modifying anti-rheumatic drug use in pregnant women with rheumatic diseases: a systematic review of the risk of congenital malformations.

Baldwin C, Avina-Zubieta A, Rai SK, Carruthers E, De Vera MA.

Clin Exp Rheumatol. 2016 Mar-Apr;34(2):172-83. Epub 2016 Mar 3. Review.

PMID:
26940667
8.

What are the effects of medication adherence interventions in rheumatic diseases: a systematic review.

Galo JS, Mehat P, Rai SK, Avina-Zubieta A, De Vera MA.

Ann Rheum Dis. 2016 Apr;75(4):667-73. doi: 10.1136/annrheumdis-2014-206593. Epub 2015 Feb 9. Review.

PMID:
25667208
9.

Systematic review and meta-analysis of validation studies on a diabetes case definition from health administrative records.

Leong A, Dasgupta K, Bernatsky S, Lacaille D, Avina-Zubieta A, Rahme E.

PLoS One. 2013 Oct 9;8(10):e75256. doi: 10.1371/journal.pone.0075256. eCollection 2013. Review.

10.

The validity of administrative data to identify hip fractures is high--a systematic review.

Hudson M, Avina-Zubieta A, Lacaille D, Bernatsky S, Lix L, Jean S.

J Clin Epidemiol. 2013 Mar;66(3):278-85. doi: 10.1016/j.jclinepi.2012.10.004. Review.

PMID:
23347851
11.

Allogeneic peripheral blood stem cell transplantation using reduced intensity versus myeloablative conditioning regimens for the treatment of leukemia.

Vela-Ojeda J, García-Ruiz Esparza MA, Tripp-Villanueva F, Ayala-Sánchez M, Delgado-Lamas JL, Garcés-Ruiz O, Rubio-Jurado B, Montiel-Cervantes L, Sánchez-Cortés E, García-Chavez J, Xolotl-Castillo M, Rosas-Cabral A, Salazar-Exaire D, Galindo-Rodríguez G, Aviña-Zubieta A.

Stem Cells Dev. 2004 Oct;13(5):571-9.

PMID:
15588514
12.

Molecular heterogeneity of prolactin in the plasma of patients with systemic lupus erythematosus.

Cruz J, Aviña-Zubieta A, Martínez de la Escalera G, Clapp C, Lavalle C.

Arthritis Rheum. 2001 Jun;44(6):1331-5.

13.

High dose intravenous immunoglobulin (IVIg) in severe refractory rheumatoid arthritis: no evidence for efficacy.

Maksymowych WP, Aviña-Zubieta A, Luong M, Russell AS.

Clin Exp Rheumatol. 1996 Nov-Dec;14(6):657-60.

PMID:
8978962
14.

An open study of pentoxifylline in the treatment of severe refractory rheumatoid arthritis.

Maksymowych WP, Avina-Zubieta A, Luong MH, Russell AS.

J Rheumatol. 1995 Apr;22(4):625-9.

PMID:
7791152
15.

Research in rheumatology: a six-month review of selected medical journals.

Ramos-Remus C, Orozco-Barocio G, Suarez-Almazor M, Olguin-Redes J, Gomez-Vargas A, Avina-Zubieta A.

Clin Exp Rheumatol. 1993 Jan-Feb;11(1):71-4.

PMID:
8453803

Supplemental Content

Loading ...
Support Center